Evercore ISI Reaffirms Their Hold Rating on DR Horton (DHI)
Evercore ISI analyst Stephen Kim maintained a Hold rating on DR Horton today and set a price target of $153.00.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
According to TipRanks, Kim is a 5-star analyst with an average return of 15.2% and a 60.61% success rate. Kim covers the Consumer Cyclical sector, focusing on stocks such as Lennar, Mohawk, and DR Horton.
In a report released on April 8, Wells Fargo also assigned a Hold rating to the stock with a $147.00 price target.
Based on DR Horton’s latest earnings release for the quarter ending December 31, the company reported a quarterly revenue of $6.89 billion and a net profit of $594.8 million. In comparison, last year the company earned a revenue of $7.61 billion and had a net profit of $844.9 million
Based on the recent corporate insider activity of 63 insiders, corporate insider sentiment is negative on the stock. This means that over the past quarter there has been an increase of insiders selling their shares of DHI in relation to earlier this year. Most recently, in February 2026, Michael J. Murray, the EVP & COO of DHI sold 120.00 shares for a total of $17,875.20.
Read More on DHI:
Disclaimer & DisclosureReport an Issue
- D.R. Horton price target lowered to $147 from $155 at Wells Fargo
- D.R. Horton price target lowered to $128 from $129 at Barclays
- D.R. Horton downgraded to Neutral from Buy at Seaport Research
- U.S. Mortgage Rates Ramp to 6-Month High as Spring Home-Buying Season Kicks Off
- DR Horton Expands Credit Facilities to Boost Liquidity
